1. رفرنس های متنی مثل خروجی کراس رف را در اینجا وارد کرده و تایید کنید
1. Zaka M, Mahmood KT. Pre-menstrual syndrome-a review. J Pharm Sci Res 2012; 4: 1684-1691.
2. Stoner R, Camilleri V, Calleja-Agius J, Schembri-Wismayer P. The cytokine-hormone axisthe link between premenstrual syndrome and postpartum depression. Gynecol Endocrinol 2017; 33: 588-592. [
DOI:10.1080/09513590.2017.1318367] [
PMID]
3. Speroof L, Fritz M. Clinical gynecology endocrinology and infertility. 7th Ed. Philadelphia; Lippincott Williams & Wilkins; 2005.
4. Hariri FZ, Moghaddam-Banaem L, Siah Bazi S, Saki Malehi A, Montazeri A. The Iranian version of the premenstrual symptoms screening tool (PSST): a validation study. Arch Womens Ment Health 2013; 16: 531-537. [
DOI:10.1007/s00737-013-0375-6] [
PMID]
5. Farokh-Eslamlou HR, Nabilou B, Oshnoee S, Akbari E. [The prevalence of premenstrual syndrome and its associated factors among medical students of Urmia University of medical sciences.] J Urmia Univ Med Sci 2013; 24: 702-710. (in Persian)
6. Ozgoli G, Selselei E, Alavi Majd H. [Severity of premenstrual syndrome and its related factors in students of ShahidBeheshti University of medical sciences.] Advances in Nursing & Midwifery 2010; 20: 1-5. (in Persian)
7. Talaei A, Fayyazi Bordbar MR, Nasiraei A, Dadgar S, Samari A. [Epidemiology of premenstrual syndrome (PMS) in Students of Mashhad University of Medical Science]. Iran J Obstet Gynecol Infertil 2009; 12: 15-22. (in Persian)
8. Direkvand-Moghadam A, Saeyhmiri K, Delpisheh A, Kaikhavandi S. Epidemiology of Premenstrual Syndrome (PMS)-A Systematic Review and Meta-Analysis Study. J Clin Diagn Res 2014; 8:106-109.
9. Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol 2012; 162: 83-86. [
DOI:10.1016/j.ejogrb.2012.01.017] [
PMID]
10. Sarkar AP, Mandal R, Ghorai S. Premenstrual syndrome among adolescent girl studentsin a rural school of West Bengal, India. Int J Med Sci Public Health 2016; 5: 408-411. [
DOI:10.5455/ijmsph.2016.2407201566]
11. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr 1988; 47: 636-641. [
DOI:10.1093/ajcn/47.4.636] [
PMID]
12. Saeedian kia A, Amani R, Cheraghian B. The Association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among University Students: A case control study. Health Promot Perspect 2015; 5: 225-230. [
DOI:10.15171/hpp.2015.027] [
PMID]
13. Fathizadeh S, Amani R, Haghighizadeh MH, Hormozi R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study. Int J Reprod Biomed 2016; 14: 699-704. [
DOI:10.29252/ijrm.14.11.699]
14. Shamberger RJ. Calcium, magnesium, and other elements in the red blood cells and hair of normals and patients with premenstrual syndrome. Biol Trace Elem Res 2003; 94: 123-129. [
DOI:10.1385/BTER:94:2:123]
15. Chocano-Bedoya PO, Manson JE, Hankinson SE, Johnson SR, Chasan-Taber L, Ronnenberg AG, et al. Intake of selected minerals and risk of premenstrual syndrome. Am J Epidemiol 2013; 177: 1118-1127. [
DOI:10.1093/aje/kws363] [
PMID]
16. Stewart A. Clinical and biochemical effects of nutritional supplementation on the premenstrual syndrome. J Reprod Med 1987; 32: 435-441.
17. Lovick TA, Guapo VG, Anselmo-Franci JA, Loureiro CM, Faleiros MCM, Del Ben CM, et al. A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms. Psychoneuroendocrinology 2017; 75: 83-90. [
DOI:10.1016/j.psyneuen.2016.10.024] [
PMID]
18. Rajaei S, Akbari Sene A, Norouzi S, Berangi Y, Arabian S, Lak P, et al. The relationship between serum vitamin D level and premenstrual syndrome in Iranian women. Int J Reprod Biomed 2016; 14: 665-668. [
DOI:10.29252/ijrm.14.10.665]
19. Dadkhah H, Ebrahimi E, Fathizadeh N. Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome: A randomized, double-blind, controlled trial. Iran J Nurs Midwifery Res 2016; 21: 159-164. [
DOI:10.4103/1735-9066.178237] [
PMID]
20. Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 2009; 105: 158-161. [
DOI:10.1016/j.ijgo.2009.01.016] [
PMID]
21. Obeidat BA, Alchalabi HA, Abdul-Razzak KK, Al-Farras MI. Premenstrual symptoms in dysmenorrheic college students: prevalence and relation to vitamin D and parathyroid hormone levels. Int J Environ Res Public Health 2012; 9: 4210-4222. [
DOI:10.3390/ijerph9114210] [
PMID]
22. Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health 2014; 14: 56. [
DOI:10.1186/1472-6874-14-56] [
PMID]
23. Groves NJ, McGrath JJ, Burne TH. Vitamin D as a neurosteroid affecting the developing and adult brain. Ann Rev Nutr 2014; 34: 117-141. [
DOI:10.1146/annurev-nutr-071813-105557] [
PMID]
24. Bertone-Johnson ER, Ronnenberg AG, Houghton SC, Nobles C, Zagarins SE, Takashima-Uebelhoer BB, et al. Association of inflammation markers with menstrual symptom severity and premenstrual syndrome in young women. Hum Reprod 2014; 29: 1987-1994. [
DOI:10.1093/humrep/deu170] [
PMID]
25. Rajaei S, Dabbagh A. The molecular mechanisms of Vitamin D effects on alleviating premenstrual syndrome pain. Journal of Cellular and Molecular Anesthesia 2017; 2: 30-36.
26. Güleç Yılmaz S, Gül T, Attar R, Yıldırım G, İşbir T. Association between fok1polymorphism of vitamin D receptor gene with uterine leiomyoma in Turkish populations. J Turk Ger Gynecol Assoc 2018; 19: 128-131. [
DOI:10.4274/jtgga.2018.0002] [
PMID]
27. Dasgupta S, Dutta J, Annamaneni S, Kudugunti N, Battini MR. Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women. Indian J Med Res 2015; 142: 276-285. [
DOI:10.4103/0971-5916.166587] [
PMID]
28. Hussain S, Hussain S, Abdraboh NR. Vitamin D receptor Fok1 polymorphism and its relationship with premenstrual syndrome. Gene Reports 2018; 12: 324-328. [
DOI:10.1016/j.genrep.2018.08.001]
29. Ahmadi S, Mirzaei K, Hossein-Nezhad A, Shariati G. Vitamin D receptor FokI genotype may modify the susceptibility to schizophrenia and bipolar mood disorderby regulation of dopamine D1 receptor gene expression. Minerva Med 2012; 103: 383-391.
30. Glocke M, Lang F, Schaeffeler E, Lang T, Schwab M, Lang UE. Impact of vitamin D receptor VDR rs2228570 polymorphism in oldest old. Kidney Blood Press Res 2013; 37: 311-322. [
DOI:10.1159/000350159] [
PMID]